With the “Virtual Accelerator for Smart data, medical devices and therapies @ Leipzig Heart" makes it easier for young medical technology companies to take the last step to the market. But from the beginning of 2021, even bigger plans are being planned in Saxony.
The regulatory framework and requirements of the medical technology industry present start-ups and founding teams with particular organizational and financial challenges. This is where the accelerator of the Saxon industry association for biotechnology and medical technology – biosaxony e. V. – the Leipzig Heart Institute and the Heart Center Leipzig. The 12-month program focuses on industry-specific topics such as approval, marketing, reimbursement and clinical evidence. Through individual coaching and mentoring as well as a market-specific training offer, selected start-ups are supported in further developing their software solutions and devices into finished medical products and implementing them in the clinical environment.
In the current pilot run, five start-ups are benefiting from the know-how and network of mentors with start-up and industry experience: Cardiomo Care is developing a mobile ECG system that allows continuous monitoring of vital signs outside of medical facilities. Next3D establishes a new process for manufacturing individualized stents based on 3D printing. Ebnet Medical presented a new type of catheter system that is intended to prevent complications from kinking in clinical use. Mindance presents an app for the care of patients with heart diseases in the home environment.
AICURA Medical is developing a system for using artificial intelligence to support doctors in everyday clinical work. The project is financed by the City of Leipzig, the Leipzig Heart Institute and the Heart Center Leipzig.
At the beginning of 2021, the accelerator will have a physical presence with the "Medical Forge": Office and laboratory space for up to eight start-ups will then be made available free of charge in BIO CITY LEIPZIG. Together with partners from industry, health insurance companies, notified bodies and of course clinics, the founders will continue to forge their products and services in order to bring them to market maturity.
"With the Medical Forge we are looking for new concepts for diagnosis and therapy, whereby the technological basis is not specified - from imaging to artificial intelligence to 5G applications, all applications are welcome," says biosaxony Managing Director André Hofmann, A corresponding call for projects will be published by biosaxony in spring - those who are very curious can register as interested parties in advance at email@example.com.